News
In the present investigation, the impact of nonthermal, cold plasma treatment on the physicochemical, nutritional, functional, thermal, and amino acid composition of chicken breast powder (CBP) was ...
Around 3,000 lives could be saved and 5,500 hospital admissions prevented each year by changes to how people are treated for heart failure, according to a watchdog. New draft guidelines from the ...
Hematopoietic stem cell transplantation (HSCT) use in CLL decreased by 42% from 2009 to 2018 due to new treatment options. Non-relapse mortality (NRM) improved significantly, attributed to ...
The security issue of wireless Implantable Medical Devices (IMD) is an emerging area of research. The unique challenge here is that an IMD should be accessed by doctors with no authorization for ...
In this Woman's Doctor segment, breast cancer treatment can be grueling, and it can also make for long days. A new study shows higher doses of radiation given over fewer sessions was as effective ...
Understanding Cancer Changes and Testing: How Testing Guides Your Metastatic Breast Cancer Treatment
Panelists discuss how testing for specific changes in cancer cells, like ESR1 mutations, ... This understanding fundamentally changes how clinicians approach treatment sequencing in hormone ...
Understanding Cancer Changes and Testing: How Testing Guides Your Metastatic Breast Cancer Treatment
Panelists discuss how testing for specific changes in cancer cells, like ESR1 mutations, ... This understanding fundamentally changes how clinicians approach treatment sequencing in hormone ...
Join the journey to enhanced spine health with lifestyle changes in Jersey City, NJ, and uncover transformative benefits. ... making healthy changes is crucial to making spine treatment benefits last.
Of the 39 patients with ECG changes (baseline + new onset post‐PPVI + new onset at follow‐up), 27 patients had ECG for analysis (Figures 5, 6 through 7). Specifically, there were 19 resolved ST/T ...
Clinical and laboratory results demonstrated no drug-related adverse events, no ECG changes and no hypoglycemia with TIX100 exhibiting a favorable safety profile and predictable pharmacokinetics, ...
Background: Amivantamab (ami) is an FDA- and EMA-approved EGFR-MET bispecific antibody with immune cell–directing activity for EGFR-mutated advanced non-small cell lung cancer.Ami monotherapy has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results